Trends of Biopsy-Proven Kidney Diseases in Romania: A Single-Center Registry Report Spanning 28 Years

罗马尼亚经活检证实的肾脏疾病趋势:一项跨越28年的单中心注册研究报告

阅读:2

Abstract

RATIONALE & OBJECTIVE: The epidemiologic landscape of biopsy-proven kidney diseases in Romania and its evolution over time are poorly understood. STUDY DESIGN: Register-based single-center retrospective study. SETTING & PARTICIPANTS: Adult native kidney biopsy records between 1996 and 2023 from the registry of the Victor Babeş National Institute of Pathology, Bucharest, Romania. PREDICTOR: Year of biopsy. OUTCOMES: Histopathological diagnosis. ANALYTICAL APPROACH: Temporal trends in participant demographics and frequency of histopathological diagnoses were evaluated using regression analyses. RESULTS: We identified a total of 1,937 adult native kidney biopsy records. The median age at diagnosis was 46 years (IQR, 33-58 years), and men represented 54.5% of participants. Immunoglobulin A nephropathy was the most common diagnosis (15.4%), followed by membranous nephropathy (12.5%), focal segmental glomerulosclerosis (8.3%), minimal change disease (8.2%), lupus nephritis (7.0%), and diabetic nephropathy (6.9%). Our results indicate a change in demographic composition of the population biopsied, reflected in an increase in the median age at biopsy over time, and a decrease in the male proportion in recent periods. We identified historically increasing immunoglobulin A nephropathy and diabetic nephropathy frequencies, and decreasing membranous nephropathy and minimal change disease frequencies, which stabilized over more recent periods. In contrast, lupus nephritis registered an increasing trend that was maintained in recent times. LIMITATIONS: This is a single-center study and does not report on the clinical data of the participants. CONCLUSIONS: Our findings, corroborated with those of other centers in Romania, suggest that kidney disease trends in the Romanian population largely align with those reported in other European registries. However, we echo concerns voiced in other biopsy registry studies, regarding the challenges encountered in attempting direct comparisons between published reports within and across countries.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。